{"id":"W2479909615","doi":"10.14785/lymphosign-2016-0004","title":"Efficacy, safety, and tolerability of Kedrion 10% IVIG in primary immunodeficiency","year":2016,"lang":"en","type":"article","venue":"LymphoSign Journal","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; Brampton Civic Hospital","funders":"","keywords":"Tolerability; Medicine; Primary immunodeficiency; Adverse effect; Pharmacokinetics; Off-label use; Clinical endpoint; Discontinuation; Pediatrics; Internal medicine; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001090083,0.0002024242,0.0004598949,0.0001932825,0.0002274574,0.00001562305,0.0003352682,0.0001995369,0.0007434683],"category_scores_gemma":[0.0001645137,0.0001361554,0.0001277295,0.0002021261,0.0005069336,0.0002165332,0.0001138623,0.0002199642,0.00007824161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001518505,"about_ca_system_score_gemma":0.0001995342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005613069,"about_ca_topic_score_gemma":0.00000107405,"domain_scores_codex":[0.99811,0.0002602839,0.0008324126,0.0002640729,0.00007442725,0.0004587837],"domain_scores_gemma":[0.9990748,0.0002350156,0.0003065014,0.0002926486,0.00007919741,0.00001185739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0013455,0.0004916662,0.005870911,0.00002027395,0.00004335349,0.000005367497,0.0008120094,0.000009171878,0.72242,0.0004872501,0.0001141794,0.2683803],"study_design_scores_gemma":[0.02016702,0.000909047,0.879725,0.0007171171,0.00005626283,0.001232455,0.0005467653,0.000007975698,0.05707461,0.002003266,0.03688344,0.0006769767],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9506063,0.04417128,0.001423376,0.0004347698,0.0005060554,0.0001729933,0.00001062853,0.00002386727,0.00265067],"genre_scores_gemma":[0.9974781,0.001557016,0.00003241932,0.00006264055,0.0000038581,0.000003157776,0.000006096447,0.00001349121,0.00084317],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8738542,"threshold_uncertainty_score":0.8140456,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006136023571688539,"score_gpt":0.2049729752206945,"score_spread":0.198836951649006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}